You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

PLETAL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pletal, and when can generic versions of Pletal launch?

Pletal is a drug marketed by Otsuka and is included in one NDA.

The generic ingredient in PLETAL is cilostazol. There are twelve drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cilostazol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pletal

A generic version of PLETAL was approved as cilostazol by EPIC PHARMA LLC on November 23rd, 2004.

  Try a Trial

Drug patent expirations by year for PLETAL
Recent Clinical Trials for PLETAL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Asan Medical CenterPhase 4
Kangbuk Samsung HospitalPhase 4
University of EdinburghPhase 2

See all PLETAL clinical trials

US Patents and Regulatory Information for PLETAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka PLETAL cilostazol TABLET;ORAL 020863-001 Jan 15, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Otsuka PLETAL cilostazol TABLET;ORAL 020863-002 Jan 15, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.